NEM
40
3
IBM
47
-3
CMI
64
-3
DRI
50
-3
GOOG
57
-6
WMT
56
-4
BDX
56
10
COF
62
3
M
31
-3
CVX
43
-3
TDC
67
-4
HAS
30
-2
CMS
60
2
PEG
62
4
ADSK
66
-4
DE
42
3
AAP
35
-9
MCD
52
-5
ROST
57
-3
DD
53
-6
NEM
40
3
IBM
47
-3
CMI
64
-3
DRI
50
-3
GOOG
57
-6
WMT
56
-4
BDX
56
10
COF
62
3
M
31
-3
CVX
43
-3
TDC
67
-4
HAS
30
-2
CMS
60
2
PEG
62
4
ADSK
66
-4
DE
42
3
AAP
35
-9
MCD
52
-5
ROST
57
-3
DD
53
-6
Financhill
Back

Voya Global Equity Dividend and Premium Opportunity Fund Vs. Avidity Biosciences Industry Stock Comparison

Sell
45

IGD
Voya Global Equity Dividend and Premium Opportunity Fund

Last Price:
5.51
Seasonality Move:
-0.93%
Sell
28

RNA
Avidity Biosciences

Last Price:
42.16
Seasonality Move:
39.98%
Sell
45
Voya Global Equity Dividend and Premium Opportunity Fund (IGD) is a Sell

Is Voya Global Equity Dividend and Premium Opportunity Fund a Buy, Sell or Hold?

  • The current Voya Global Equity Dividend and Premium Opportunity Fund [IGD] share price is $5.51. The Score for IGD is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • IGD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Avidity Biosciences (RNA) is a Sell

Is Avidity Biosciences a Buy, Sell or Hold?

  • The current Avidity Biosciences [RNA] share price is $42.18. The Score for RNA is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • RNA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

IGD Stock Price Chart

What is Voya Global Equity Dividend and Premium Opportunity Fund's stock price today?

RNA Stock Price Chart

What is Avidity Biosciences's stock price today?

  • The Avidity Biosciences share price today is $42.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNA is experiencing selling pressure, which indicates risk of future bearish movement.

IGD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 50.21 Buy
Chaikin Money Flow: -39778 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.43 - 5.59) Sell
Bollinger Bands (100): (5.34 - 5.64) Buy

RNA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.53 Buy
Relative Strength Index (14 RSI): 42.17 Sell
Chaikin Money Flow: -1839481 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.78 - 48.76) Sell
Bollinger Bands (100): (41.56 - 46.96) Sell

IGD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.51 Buy
20-day SMA: 5.49 Buy
50-day SMA: 5.55 Sell
200-day SMA: 5.31 Buy
8-day EMA: 5.5 Buy
20-day EMA: 5.5 Buy
50-day EMA: 5.51 Sell
200-day EMA: 5.36 Buy

RNA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.51 Sell
20-day SMA: 45.87 Sell
50-day SMA: 45.1 Sell
200-day SMA: 34.2 Buy
8-day EMA: 46.84 Sell
20-day EMA: 46.32 Sell
50-day EMA: 45.24 Sell
200-day EMA: 35.58 Buy

Voya Global Equity Dividend and Premium Opportunity Fund Earnings Growth & IGD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Avidity Biosciences Earnings Growth & RNA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and a decrease next year of $0.25 per share.

Voya Global Equity Dividend and Premium Opportunity Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Avidity Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):